<DOC>
	<DOC>NCT01618955</DOC>
	<brief_summary>The purpose of this study is to assess the usability of the VIBEX MTX device for SC self-injection of methotrexate.</brief_summary>
	<brief_title>Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEXâ„¢ MTX Auto-Injector Device</brief_title>
	<detailed_description>Primary objective: - To assess the safe usability of the VIBEX MTX device for subcutaneous (SC) self-injection of methotrexate (MTX) in adult patients with rheumatoid arthritis (RA) after standardized training by site personnel and review of written instructions Secondary objectives: - To evaluate the reliability and robustness of the VIBEX MTX device - To evaluate the safety and local tolerance of an SC self-injection of MTX using the VIBEX MTX device - To evaluate the effectiveness and ease of use of the VIBEX MTX device patient education tools for SC self-injection</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Male or female patients &gt;18 years of age, diagnosed with Rheumatoid Arthritis Pregnant females Any other clinically significant disease or disorder which, in the opinion of the investigator might put the subject at risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>